BeOne Medicines (BEIGF) Change in Taxes (2016 - 2021)

BeOne Medicines (BEIGF) has reported Change in Taxes for 6 consecutive years, with $7.1 million the latest figure, recorded in Q1 2021.

• On a quarterly basis, Change in Taxes rose 17.58% year-over-year to $7.1 million in Q1 2021; TTM through Mar 2021 was $3.4 million, a 73.27% decrease from a year earlier, with the FY2020 full-year figure at $2.3 million, down 69.35% from the prior year.
• Change in Taxes was $7.1 million for Q1 2021 at BeOne Medicines, down from $14.6 million in the prior quarter.
• Over five years, Change in Taxes peaked at $14.6 million in Q4 2020 and troughed at -$9.3 million in Q3 2020.
• A 5-year average of $1.2 million and a median of $969000.0 in 2019 frame the typical range for Change in Taxes.
• Across the five-year window, Change in Taxes surged 5251.52% in 2017 and slumped 1730.22% in 2018, its largest moves.
• Over 5 years, Change in Taxes stood at $6.3 million in 2017, then tumbled by 32.55% to $4.3 million in 2018, then increased by 3.32% to $4.4 million in 2019, then soared by 232.14% to $14.6 million in 2020, then plunged by 51.0% to $7.1 million in 2021.
• The last three Change in Taxes figures came in at $7.1 million (Q1 2021), $14.6 million (Q4 2020), and -$9.3 million (Q3 2020), per Business Quant data.